Neurology – Page 3

Hematoma Location as a Key Modifier of Intensive Blood Pressure Lowering Outcomes in Acute Intracerebral Hemorrhage

By MedXY 10/16/2026

This pooled analysis of INTERACT and ATACH-II trials reveals that intensive blood pressure lowering significantly improves outcomes only in patients with deep intracerebral hemorrhage, highlighting hematoma location as crucial for personalized ICH management.

Clinical Updates Neurology news

Effectiveness of Office-Based Vergence/Accommodative Therapy with Movement for Accommodative Dysfunction in Concussion-Related Convergence Insufficiency: Insights from the CONCUSS Randomised Clinical Trial

By MedXY 10/16/2026

Office-based vergence/accommodative therapy with movement (OBVAM) significantly improves accommodative amplitude and facility in adolescents and young adults with concussion-related convergence insufficiency, accelerating recovery and functional return compared to delayed treatment.

Neurology news Rehabilitation Medicine

Comparative Effectiveness of High-Intensity Laser Therapy Versus Shock Wave Therapy in Post-Burn Cubital Tunnel Syndrome: A Randomized Controlled Trial

By MedXY 10/16/2026

This RCT demonstrates that high-intensity laser therapy combined with ulnar nerve gliding exercises yields superior electrophysiological and functional recovery in post-burn cubital tunnel syndrome compared to shock wave therapy or exercises alone.

Neurology news Rehabilitation Medicine

Streamlining Social Cognition Assessment Post-Traumatic Brain Injury: Validity and Reliability of the Norwegian Short-Awareness of Social Inference Test

By MedXY 10/15/2026

This article discusses the development and validation of a concise Norwegian tool to assess social cognition deficits in traumatic brain injury patients, maintaining reliability and clinical feasibility compared to the full version.

Emergency Medicine Neurology news

Differentiating Acute Imbalance Syndrome from Acute Vestibular Syndrome in Stroke-Related Vertigo: Clinical and Neuroanatomical Insights

By MedXY 10/15/2026

Acute Imbalance Syndrome represents over half of stroke-related vertigo cases, distinct from Acute Vestibular Syndrome by lesion location and clinical presentation, crucial for accurate stroke diagnosis in emergency care.

Neurology news

Enhancing Stroke Rehabilitation: Impact of Blood Flow Restriction Training on Lower Limb Function and Balance

By MedXY 10/15/2026

A randomized clinical trial demonstrates that blood flow restriction training, through BFR-walking or low-load resistance training, improves lower limb motor function and balance in stroke survivors beyond conventional rehabilitation.

Neurology news Public Health

Subjective Social Status and Stroke Recovery: Insights from a Prospective Cohort Study

By MedXY 10/14/2026

This study investigates how patients’ perceived social standing influences stroke recovery at 3 and 12 months, highlighting the role of psychological distress and identifying subjective social status as a key social determinant of long-term outcomes.

Neurology news Pediatrics

Validating the Norwegian Pediatric Family Needs Questionnaire: Reliable Insights into Family Needs Post-Acquired Brain Injury

By MedXY 10/14/2026

The Norwegian Pediatric Family Needs Questionnaire (FNQ-P) demonstrates excellent reliability and validity for assessing family needs in children with acquired brain injury, supporting its clinical and research utility.

Neurology news Psychiatry

ADHD and Risk of Late-Life Cognitive Impairment: Insights from Clinical and Genetic Data

By MedXY 10/13/2026

A comprehensive cohort study demonstrates that ADHD significantly increases the risk of mild cognitive impairment and dementia in older adults, highlighting the need for targeted monitoring and integrated care in this vulnerable population.

Neurology news OB/GYN & Women's Health

Navigating the Risks of Enzyme-Inducing Antiseizure Medications and Hormonal Contraceptive Interactions in Women with Epilepsy

By MedXY 10/13/2026

This article examines the prevalent coprescription of enzyme-inducing antiseizure medications (ASMs) and susceptible hormonal contraceptives among US Medicaid beneficiaries with epilepsy, highlighting patient risk factors and implications for clinical practice.

Neurology news Pediatrics

Elevated Mental Health Risks in Adolescents Following Mild Traumatic Brain Injury: Insights from a Large Retrospective EHR Study

By MedXY 10/13/2026

Adolescents who sustain mild traumatic brain injury (mTBI) face a significantly higher risk of developing mental health disorders over the subsequent year, influenced by factors such as sex, socioeconomic status, and prior psychiatric history. Early screening and intervention are crucial.

Neurology news

Physical Activity and Motor and Cognitive Progression in Parkinson Disease: A Longitudinal Cohort Study

By MedXY 10/12/2026

This study links higher physical activity levels with slower cognitive and motor decline in Parkinson's disease, highlighting the importance of sustained activity engagement.

Neurology news Rehabilitation Medicine

Impact of OTC Analgesics on Concussion Recovery: Insights from the CARE Consortium Study

By MedXY 10/12/2026

Over-the-counter analgesic use after concussion is linked to reduced symptom severity and faster return to unrestricted play, highlighting their potential role in postconcussion management.

Neurology news Public Health

High Burden of Fall-Related Injuries Among Stroke Survivors in Ethiopia: Insights from a Multicenter Study in Amhara Region

By MedXY 10/12/2026

A 2024 multicenter study in Amhara, Ethiopia found nearly 80% of stroke survivors experienced fall-related injuries, with older age, rural residency, and walking/turning activities as key risk factors.

Hematology-Oncology Neurology news

Decoding Risks of Chemotherapy-Induced Peripheral Neurotoxicity: Clinical Predictors of Dose-Limiting and Persistent Neurologic Toxicity

By MedXY 10/10/2026

This multisite study identifies key clinical predictors including age, sex, BMI, diabetes, and prior neurotoxic treatments that contribute to chemotherapy-induced peripheral neurotoxicity (CIPN), affecting dose tolerance and long-term patient outcomes.

Clinical Updates Neurology news Pathology & Lab Medicine

Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and Temporal Cortex Pathology in Alzheimer Disease

By MedXY 10/10/2026

Plasma pTau217 levels measured by Lumipulse G assays strongly correlate with postmortem temporal cortex pTau217 pathology, supporting plasma pTau217 as a reliable biomarker for brain tau pathology in Alzheimer disease.

Clinical Updates Neurology news

Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: Insights from the OPERA I and II Randomized Clinical Trials and Related Evidence

By MedXY 10/10/2026

Continuous ocrelizumab treatment over 10 years in relapsing MS significantly delays disability progression, reduces relapse rates, and maintains a favorable safety profile, underscoring the clinical benefit of early high-efficacy therapy.

Neurology news

Decoding Upper Cervical Cord Atrophy in Multiple Sclerosis: Separating Aging from Disease Effects

By MedXY 10/09/2026

This study clarifies that cervical cord atrophy in MS is partly disease-specific beyond aging effects, with distinct patterns linked to age and disease onset, correlating with disability and neurodegeneration markers.

Neurology news Pediatrics

Transforming Pediatric Neurology Care: The Impact of Rapid Whole-Genome Sequencing in Inpatient Diagnosis and Management

By MedXY 10/09/2026

Rapid whole-genome sequencing (WGS) in pediatric neurology inpatients yields nearly 50% diagnostic confirmation, significantly influencing patient management and supporting early genomic testing beyond neonatal intensive care units.

Clinical Updates Neurology news Pathology & Lab Medicine

Earlier Disclosure of Blood-Based Biomarkers Enhances Diagnostic Certainty and Clinical Management in Cognitive Disorders: A Review of a Recent Randomized Clinical Trial

By MedXY 10/09/2026

Early disclosure of plasma p-tau217 and NfL biomarkers significantly improves diagnostic confidence and clinical decisions in cognitive decline without increasing emotional distress, supporting their integration into routine memory clinic care.